150 related articles for article (PubMed ID: 12380199)
1. Hirsuties.
Dawber RP
J Gend Specif Med; 2002; 5(5):34-42. PubMed ID: 12380199
[TBL] [Abstract][Full Text] [Related]
2. Hirsutism.
Morris DV
Clin Obstet Gynaecol; 1985 Sep; 12(3):649-74. PubMed ID: 3905161
[TBL] [Abstract][Full Text] [Related]
3. Hirsutism: diagnosis and management.
Mercurio MG
J Gend Specif Med; 2001; 4(2):29-34, 64. PubMed ID: 11480095
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone for hirsutism in polycystic ovary syndrome.
Christy NA; Franks AS; Cross LB
Ann Pharmacother; 2005 Sep; 39(9):1517-21. PubMed ID: 16076921
[TBL] [Abstract][Full Text] [Related]
5. The clinical evaluation of hirsutism.
Somani N; Harrison S; Bergfeld WF
Dermatol Ther; 2008; 21(5):376-91. PubMed ID: 18844715
[TBL] [Abstract][Full Text] [Related]
6. [Hirsutism].
van Zuuren EJ; Pijl H
Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
[TBL] [Abstract][Full Text] [Related]
7. [Virilization in women. Clinical and therapeutic aspects].
Molinatti GM; Messina M; Monaco A; Passera P
Minerva Endocrinol; 1993 Mar; 18(1):1-11. PubMed ID: 8232116
[TBL] [Abstract][Full Text] [Related]
8. Understanding the causes and management of hirsutism.
Watts J
Nurs Times; 2006 Feb 21-27; 102(8):26-8. PubMed ID: 16519031
[TBL] [Abstract][Full Text] [Related]
9. [Hirsutism].
Rouiller DG
Rev Med Suisse; 2005 Feb; 1(6):420-4. PubMed ID: 15786646
[TBL] [Abstract][Full Text] [Related]
10. Investigations in the assessment and management of patients with hirsutism.
Barth JH
Curr Opin Obstet Gynecol; 1997 Jun; 9(3):187-92. PubMed ID: 9263703
[TBL] [Abstract][Full Text] [Related]
11. Hirsutism.
Mauvais-Jarvis P; Kuttenn F; Mowszowicz I
Monogr Endocrinol; 1981; 19():1-116. PubMed ID: 6454061
[No Abstract] [Full Text] [Related]
12. Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.
Rathnayake D; Sinclair R
Dermatol Clin; 2010 Jul; 28(3):611-8. PubMed ID: 20510769
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of androgen excess among patients with minimal unwanted hair growth.
Souter I; Sanchez LA; Perez M; Bartolucci AA; Azziz R
Am J Obstet Gynecol; 2004 Dec; 191(6):1914-20. PubMed ID: 15592272
[TBL] [Abstract][Full Text] [Related]
14. [Current opinions on the etiology and pathophysiology of hirsutism].
Krysiak R; Kedzia A; Okopień B
Pol Merkur Lekarski; 2012 May; 32(191):335-40. PubMed ID: 22779343
[TBL] [Abstract][Full Text] [Related]
15. Dermatology of androgen-related disorders.
Essah PA; Wickham EP; Nunley JR; Nestler JE
Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
17. What every physician should know about polycystic ovary syndrome.
Rosenfield RL
Dermatol Ther; 2008; 21(5):354-61. PubMed ID: 18844713
[TBL] [Abstract][Full Text] [Related]
18. [Hirsutism and hypertrichosis in adults: investigations and treatment].
Bennet A
Ann Dermatol Venereol; 2002 May; 129(5 Pt 2):804-12. PubMed ID: 12223963
[TBL] [Abstract][Full Text] [Related]
19. [Endocrinologic diagnosis in hirsutism and androgenetic alopecia in women].
Pichl J; Schell H
Z Hautkr; 1990 Dec; 65(12):1103-4, 1109-11. PubMed ID: 2087838
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of polycystic ovary syndrome with spironolactone or bromocriptine.
Blum I; Kaufman H; Marilus R; Rusecki Y; Chovers I
Obstet Gynecol; 1981 May; 57(5):661-5. PubMed ID: 7219917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
